Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort

Mynarek M, von Hoff K, Pietsch T, Ottensmeier H, Warmuth-Metz M, Bison B, Pfister S, Korshunov A, Sharma T, Jaeger N, Ryzhova M, Zheludkova O, Golanov A, Rushing EJ, Hasselblatt M, Koch A, Schüller U, von Deimling A, Sahm F, Sill M, Riemenschneider MJ, Dohmen H, Monoranu CM, Sommer C, Staszewski O, Mawrin C, Schittenhelm J, Brück W, Filipski K, Hartmann C, Meinhardt M, Pietschmann K, Haberler C, Slavc I, Gerber NU, Grotzer M, Benesch M, Schlegel PG, Deinlein F, von Bueren AO, Friedrich C, Juhnke BO, Obrecht D, Fleischhack G, Kwiecien R, Faldum A, Kortmann RD, Kool M, Rutkowski S.

Research article (journal) | Peer reviewed

Details about the publication

JournalJournal of Clinical Oncology (J Clin Oncol)
Volume38
Page range2028-2040
StatusPublished
Release year2020
Language in which the publication is writtenEnglish
KeywordsNonmetastatic Medulloblastoma; Early Childhood; Prospective Clinical Trial; HIT-2000

Authors from the University of Münster

Faldum, Andreas
Institute of Biostatistics and Clinical Research (IBKF)
Kwiecien, Robert
Institute of Biostatistics and Clinical Research (IBKF)